| 1 |
Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease : |
|
|
| Hamid Hosseini, Mohammad H Nowroozzadeh, Ramin Salouti, Mahmood Nejabat |
|
| Cornea. 2012; 31(3): 322 |
|
| [HTML Full text] [Google Scholar] |
|
| 2 |
Effect of Laser Photocoagulation and Intravitreal Bevacizumab Injection on Zone I Retinopathy of Prematurity |
|
|
| Won Choi, Hwan Heo |
|
| Journal of the Korean Ophthalmological Society. 2012; 53(1): 120 |
|
| [HTML Full text] [Google Scholar] |
|
| 3 |
Intravitreal Bevacizumab for Retinopathy of Prematurity |
|
|
| Björn C. Harder, Stefan von Baltz, Jost B. Jonas, Frank C. Schlichtenbrede |
|
| Journal of Ocular Pharmacology and Therapeutics. 2011; 27(6): 623 |
|
| [HTML Full text] [Google Scholar] |
|
| 4 |
Mediators involved in retinopathy of prematurity and emerging therapeutic targets |
|
|
| A. Mataftsi, S.A. Dimitrakos, G.G.W. Adams |
|
| Early Human Development. 2011; |
|
| [HTML Full text] [Google Scholar] |
|
| 5 |
Visual acuity and electroretinography findings 3 1/2 years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity |
|
|
| Shah, P.K., Morris, R.J., Narendran, V., Kalpana, N. |
|
| Indian Journal of Ophthalmology. 2011; 59(1): 73-74 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY : |
|
|
| Ruth Axer-Siegel, Moshe Snir, Yonina Ron, Ronit Friling, Lea Sirota, Dov Weinberger |
|
| Retina. 2011; 31(7): 1239 |
|
| [HTML Full text] [Google Scholar] |
|
| 7 |
Rescue Intravitreal Bevacizumab (Avastin) for Aggressive Posterior Retinopathy of Prematurity |
|
|
| Farhan Qureshi, Christopher Dewhurst, C.W. Yoxall, David Clark |
|
| Seminars in Ophthalmology. 2011; 26(2): 55 |
|
| [HTML Full text] [Google Scholar] |
|
| 8 |
Pharmacological treatment of retinopathy of prematurity: antiangiogenic or proangiogenic? |
|
|
| Akiyoshi Uemura |
|
| Expert Review of Ophthalmology. 2010; 5(2): 123 |
|
| [HTML Full text] [Google Scholar] |
|
| 9 |
New progress on the treatment of retinopathy of prematurity |
|
|
| Tan, J.-X., Zhu, D. |
|
| International Journal of Ophthalmology. 2010; 10(5): 898-900 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Pharmacological treatment of retinopathy of prematurity: Antiangiogenic or proangiogenic? |
|
|
| Uemura, A. |
|
| Expert Review of Ophthalmology. 2010; 5(2): 123-127 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity |
|
|
| Law, J.C., Recchia, F.M., Morrison, D.G., Donahue, S.P., Estes, R.L. |
|
| Journal of AAPOS. 2010; 14(1): 6-10 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage |
|
|
| Hossein Nazari, Mehdi Modarres, Mohammad Mehdi Parvaresh, Khalil Ghasemi Falavarjani |
|
| Graefe s Archive for Clinical and Experimental Ophthalmology. 2010; 248(12): 1713 |
|
| [HTML Full text] [Google Scholar] |
|
| 13 |
Intravitreal cysticercosis presenting as neovascular glaucoma |
|
|
| Ratra, D., Phogat, C., Singh, M., Choudhari, N.S. |
|
| Indian Journal of Ophthalmology. 2010; 58(1): 70-73 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Retinopathy of prematurity: Clinical insights from molecular studies |
|
|
| Heidary, G., Löfqvist, C., Mantagos, I.S., Vanderveen, D.K., Hellström, A., Smith, L.E. |
|
| NeoReviews. 2009; 10(11): e550-e557 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
New therapeutic approaches in the treatment of retinopathy of prematurity | [Neue therapeutische Ansätze in der Behandlung der Frü hgeborenenretinopathie] |
|
|
| Jandeck, C. |
|
| Klinische Monatsblatter fur Augenheilkunde. 2009; 226(11): 914-920 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema |
|
|
| |
|
| Ophthalmology. 2009; 116(8): 1488 |
|
| [HTML Full text] [Google Scholar] |
|
| 17 |
Effect of intravitreal bevacizumab (Avastin) on the growing rabbit eye |
|
|
| Axer-Siegel, R., Herscovici, Z., Hasanreisoglu, M., Kremer, I., Benjamini, Y., Snir, M. |
|
| Current Eye Research. 2009; 34(8): 660-665 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity |
|
|
| Micieli, J.A., Surkont, M., Smith, A.F. |
|
| American Journal of Ophthalmology. 2009; 148(4): 536-543, e2 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema. The Pan-American Collaborative Retina Study Group at 24 Months |
|
|
| Arevalo, J.F., Sanchez, J.G., Wu, L., Maia, M., Alezzandrini, A.A., Brito, M., Bonafonte, S., (...), Udaondo-Mirete, P. |
|
| Ophthalmology. 2009; 116(8): 1488-1497,e1 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up |
|
|
| Arevalo, F., Sanchez, J.G., Fromow-Guerra, J., Wu, L., Berrocal, M.H., Farah, M.E., Cardillo, J., Rodríguez, F.J. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2009; 247(6): 735-743 |
|
| [Pubmed] [Google Scholar] |
|
| 21 |
Retinopathy of Prematurity |
|
|
| Askin, D.F., Diehl-Jones, W. |
|
| Critical Care Nursing Clinics of North America. 2009; 21(2): 213-233 |
|
| [Pubmed] [Google Scholar] |
|
| 22 |
Bevacizumab (Avastin) for the Treatment of Ocular Disease |
|
|
| Gunther, J.B., Altaweel, M.M. |
|
| Survey of Ophthalmology. 2009; 54(3): 372-400 |
|
| [Pubmed] [Google Scholar] |
|
| 23 |
Antivascular endothelial growth factor for retinopathy of prematurity |
|
|
| Mintz-Hittner, H.A., Best, L.M. |
|
| Current Opinion in Pediatrics. 2009; 21(2): 182-187 |
|
| [Pubmed] [Google Scholar] |
|
| 24 |
Emerging treatments for retinopathy of prematurity |
|
|
| Mantagos, I.S., Vanderveen, D.K., Smith, L.E.H. |
|
| Seminars in Ophthalmology. 2009; 24(2): 82-86 |
|
| [Pubmed] [Google Scholar] |
|
| 25 |
Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity |
|
|
| Shah, P.K., Narendran, V., Kalpana, N., Tawansy, K.A. |
|
| Eye. 2009; 23(1): 176-180 |
|
| [Pubmed] [Google Scholar] |
|
| 26 |
Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. |
|
|
| MINTZ-HITTNER, H.A. and KUFFEL JR, R.R. |
|
| Retina. 2008; 28(6): 831 |
|
| [Pubmed] [Google Scholar] |
|
| 27 |
Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization |
|
|
| Mansour, A.M. and Mackensen, F. and Arevalo, J.F. and Ziemssen, F. and Mahendradas, P. and Mehio-Sibai, A. and Hrisomalos, N. and Lai, T.Y.Y. and Dodwell, D. and Chan, W.M. and others |
|
| American Journal of Ophthalmology. 2008; 146(3): 410-416 |
|
| [Pubmed] [Google Scholar] |
|
| 28 |
Intravitreal bevacizumab for neovascular glaucoma |
|
|
| Andrijević-Derk, B., Vatavuk, Z., Benčić, G., Novak-Lauš, K., Mandić, Z. |
|
| Acta Clinica Croatica. 2008; 47(3): 175-179 |
|
| [Pubmed] [Google Scholar] |
|
| 29 |
Surgical management of retinopathy of prematurity |
|
|
| Hubbard, G.B. |
|
| Current Opinion in Ophthalmology. 2008; 19(5): 384-390 |
|
| [Pubmed] [Google Scholar] |
|
| 30 |
Effect of bevacizumab (avastin) on eye diseases |
|
|
| Song, H., Ren, B., Gao, X.-W. |
|
| International Journal of Ophthalmology. 2008; 8(6): 1230-1232 |
|
| [Pubmed] [Google Scholar] |
|
| 31 |
Retinal detachment in children: Differential diagnosis and current therapy | [Netzhautablösung im kindesalter: Differenzialdiagnose und aktuelle therapieoptionen] |
|
|
| Meier, P. |
|
| Klinische Monatsblatter fur Augenheilkunde. 2008; 225(9): 779-790 |
|
| [Pubmed] [Google Scholar] |
|
| 32 |
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity |
|
|
| Honda, S., Hirabayashi, H., Tsukahara, Y., Negi, A. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2008; 246(7): 1061-1063 |
|
| [Pubmed] [Google Scholar] |
|
| 33 |
Progress of researches on Avastin in ophthalmology |
|
|
| Yu, T.-L., Bi, H.-S. |
|
| International Journal of Ophthalmology. 2008; 8(4): 810-812 |
|
| [Pubmed] [Google Scholar] |
|
| 34 |
Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population |
|
|
| Kumar, A. and Sinha, S. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 451 |
|
| [Pubmed] [Google Scholar] |
|
| 35 |
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration |
|
|
| Azad, R. and Chandra, P. and Gupta, R. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 441 |
|
| [Pubmed] [Google Scholar] |
|
| 36 |
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice |
|
|
| Hussain, N. and Ghanekar, Y. and Kaur, I. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 445 |
|
| [Pubmed] [Google Scholar] |
|
| 37 |
Combination of laser photocoagulation and intravitreal bevacizumab (Avastin{\textregistered}) for aggressive zone I retinopathy of prematurity |
|
|
| Chung, E.J. and Kim, J.H. and Ahn, H.S. and Koh, H.J. |
|
| Graefeæs Archive for Clinical and Experimental Ophthalmology. 2007; 245(11): 1727-1730 |
|
| [Pubmed] [Google Scholar] |
|
| 38 |
Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity |
|
|
| Azad, R., Chandra, P. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 319 |
|
| [Pubmed] [Google Scholar] |
|
| 39 |
Authorsæ reply |
|
|
| Shah, P.K., Narendran, V., Tawansy, K.A., Raghuram, A., Narendran, K. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 317-318 |
|
| [Pubmed] [Google Scholar] |
|
| 40 |
Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity |
|
|
| Sangtam, T., Vinekar, A., Maheshwar, B., Dogra, M.R., Eong, K.-G.A. |
|
| Indian Journal of Ophthalmology. 2007; 55(4): 317 |
|
| [Pubmed] [Google Scholar] |
|
| 41 |
Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries |
|
|
| Velpandian, T. and Sharma, C. and Garg, SP and Mandal, S. and Ghose, S. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 488 |
|
| [Pubmed] [Google Scholar] |
|
| 42 |
Off-label use of medicines: Medical research and medical practice |
|
|
| Khamar, B. |
|
| Indian Journal of Ophthalmology. 2007; 55(6): 411 |
|
| [Pubmed] [Google Scholar] |
|
| 43 |
Intravitreal bevacizumab: an analysis of the evidence |
|
|
| Smit, D.P. and Meyer, D. |
|
| Clinical Ophthalmology. 2007; 1(3): 273-284 |
|
| [Pubmed] [Google Scholar] |
|
| 44 |
Bevacizumab for ophthalmic diseases |
|
|
| Stephan Michels, Franz Prager, Sophie J Bakri, Joachim Wachtlin |
|
| Expert Review of Ophthalmology. 2007; 2(3): 369 |
|
| [HTML Full text] [Google Scholar] |
|
